Menu Search
Equities

Acarix AB

ACARIX:STO

Acarix AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)0.3335
  • Today's Change-0.002 / -0.45%
  • Shares traded4.99m
  • 1 Year change+39.67%
  • Beta1.6857
Data delayed at least 15 minutes, as of Sep 19 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in SEK

The one analyst offering a 12 month price target expects Acarix AB share price to rise to 0.50 in the next year from the last price of 0.3335.
High49.9%0.50
Med49.9%0.50
Low49.9%0.50

Earnings history & estimates in SEK

On Aug 22, 2024, Acarix AB reported 2nd quarter 2024 losses of -0.02 per share. This result was in line with the expectation of the one analyst following the company and exceeded last year's 2nd quarter results by 55.56%.
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate+11.11%
Acarix AB reported annual 2023 losses of -0.16 per share on Feb 15, 2024.
Average growth rate+11.01%
More ▼

Revenue history & estimates in SEK

Acarix AB (publ) had 2nd quarter 2024 revenues of 1.96m. This missed the 7.00m estimate of the one analyst following the company. This was 0.20% above the prior year's 2nd quarter results.
Average growth rate+8.78%
Acarix AB (publ) had revenues for the full year 2023 of 6.24m. This was 7.20% above the prior year's results.
Average growth rate+38.04%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.